Thymosin Alpha 1 Suppliers & Bulk Manufacturers
Available Forms: Lyophilized Powder for Injection
Available Strengths: 1.6 mg/vial
Reference Brands: Zadaxin® (EU & US)
Category:
Hepatitis
Thymosin Alpha 1 Injection (Zadaxin® generic) is an immunomodulatory peptide used in hepatitis, cancer immunotherapy, and viral infections. Offered in 1.6 mg/vial lyophilized form, manufactured under EU-GMP/WHO-GMP standards. Ideal for B2B supply, tenders, and licensing, with full regulatory dossiers and stability data.
Thymosin Alpha 1 is available in Lyophilized Powder for Injection
and strengths such as 1.6 mg/vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Thymosin Alpha 1 is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Thymosin Alpha 1 can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Thymosin Alpha 1 Injection is a synthetic thymic peptide with strong immunomodulatory properties, used as an adjunct therapy in chronic hepatitis B, hepatitis C, and immunodeficiency disorders. It enhances T-cell activity and antiviral responses, supporting immune regulation in liver disease and oncology patients. Supplied as a lyophilized powder (1.6 mg/vial), it is manufactured under EU-GMP or WHO-GMP standards. Ideal for B2B partnerships, hospital supply, and licensing across regulated and semi-regulated markets. Full CTD dossiers, stability data, and quality certifications are available to support registration in Europe, CIS, and other international markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing